The Partnership Will Further the Initiative of CalHOPE to Provide Outreach And Non-Clinical Emotional Support to Individuals Struggling in the State of California DANA POINT, Calif.–(BUSINESS WIRE)–Alter Health Group (AHG) is excited to announce the award of a new grant totaling over $5M from the California Mental Health Services Authority (CalMHSA). With this funding, AHG … [Read more…]
Sotatercept demonstrated statistically significant improvements in 8 of 9 secondary measures, including reduction in risk of clinical worsening or death Results presented today at ACC.23/WCC and published in The New England Journal of Medicine RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced full results from … [Read more…]
MK-0616 was generally well tolerated and reduced LDL-C across all dose levels compared to placebo Merck plans to start Phase 3 pivotal study in the second half of 2023 RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 2b clinical trial evaluating … [Read more…]
EDISON, N.J.–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined its Board of Directors. “We are honored to welcome Jeff to our Board,” said … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences. Keystone Symposia: Chromatin Architecture in Development and Human Health Poster Title: Discovery and engineering of hypercompact transcriptional modulators for robust and durable target gene activation … [Read more…]
GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak® Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation.1 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a leading organ transplant company, announces new research from a multi-center study on … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Smart Pill Market by Components, Tools and Technologies, Production Method, Distribution Channels, and Diagnostics 2023-2028” report has been added to ResearchAndMarkets.com’s offering. This report evaluates the smart pills market including the technologies, companies, and solutions for smart pill delivery, monitoring, and diagnostics. The report assesses the impact of smart pills themselves as well … [Read more…]
PaSER™ Novor faster, real-time de novo sequencing for immunopeptidomics Library-free dia-PASEF® analysis with PaSER 2023b proteomics software Partnership with Mass Dynamics for 4D-Proteomics™ knowledge visualization CHICAGO–(BUSINESS WIRE)–$BRKR #BRKR–At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in … [Read more…]
Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in … [Read more…]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that results from the Benefit of Microcore in Acute Decompensated Heart Failure (BMAD) Trial were presented today by Dr. John Boehmer, MD, of Penn State Health Milton S. Hershey Medical Center and the trial lead investigator, as … [Read more…]
